Insights On Clinical Technologies

  1. Getting to True Agile IRT: 5 Questions To Ask Your IRT Vendor
    9/4/2018

    While many vendors are claiming agile IRT capabilities, it is important to dig deeply and examine these claims – as well as a company’s proven ability to provide predictable, consistent delivery of project timelines and quality.

  2. Making eSource Work: Beyond The Hype
    9/4/2018

    Implementing eSource can mean operating differently from the norm, with potentially an initial layer of complexity before things become simpler.

  3. A Survival Guide To Temperature Data In Life Sciences
    8/22/2018

    Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire clinical supply chain.

  4. Changes to WHODrug Are Coming – Will You Be Ready?
    8/18/2018

    Why you should prepare now even with nearly a year remaining.

  5. Taking On Both Animal Health And Human Clinical Trials With One eClinical Platform
    8/18/2018

    How a CRO is leveraging the eClinical versatility necessary to succeed in a broad array of studies.

  6. Mobile eTMF: The Pain Of Yesterday.The Relief Of Today.
    8/14/2018

    Since the launch of myTI—TransPerfect’s mobile experience for the Trial Interactive eTMF—I have heard rave reviews from clinical operations leaders and CRAs. The advantages of mobile technology for clinical operations are generating a lot of excitement, and rightfully so. In my collaboration with study teams during the development, release, and ongoing evolution of myTI, we encountered many thematic pain points that were ripe for a mobile solution.

  7. On A Technology–Enabled Collision Course: Clinical Research And Clinical Practice Converge Through Real World Evidence
    8/6/2018

    Late Phase Research in the Life Sciences segment is undergoing a rapid transformation due to the digitalisation of healthcare and the greater availability of, and access to, Real World Data (RWD). This transformation is arriving not a moment too soon, given the changes anticipated from the Twenty-first Century Cures Act, EMA’s Adaptive Pathways approach, and the increased demand for Real World Evidence (RWE) generated from these RWD. In addition to supporting regulatory decisions, RWE is playing an ever expanding role in developing the product value propositions that are driving reimbursement decisions globally.

  8. New Packaging Strategy Optimizes Supplies And Prevents Break In Enrollment
    7/24/2018

    Direction from a solution provider with expertise in forecasting, packaging, labeling and distribution along with services of an IRT provider solves drug shortage challenge.

  9. Rein In The High Cost Of Cardiovascular Outcome Trials
    7/24/2018

    Three success factors for leaner operations.

  10. Maximizing Efficiencies In Site Enrollment
    7/20/2018

    Pharma companies and CROs are recognizing the need for focused electronic feasibility solutions to resolve challenges with processes managed in Excel trackers.